aav8 Search Results


aav8 vector  (PackGene Biotech lnc)
95
PackGene Biotech lnc aav8 vector
In vivo mouse PCSK9 gene editing using single <t>AAV8</t> - packaged SflSdd-CBE (nSaCas9) 2.0. ( A ) Theoretical packaging of SflSdd-CBE (nSaCas9) 2.0 into a single AAV8. The top, shows the architectures of AncBE4max (nSaCas9), BE4-gam (nSaCas9), and Sdd-CBE (nSaCas9) 2.0, with AncBE4max (nSaCas9) and BE4-gam (nSaCas9) in gray, indicating their size exceeds the single AAV packaging limit. The bottom presents a schematic representation of AAV8-SflSdd-CBE (nSaCas9) 2.0. ( B ) Experimental timeline for tail-vein injections and subsequent analyses using AAV8-SflSdd-CBE (nSaCas9) 2.0. ( C ) Editing efficiencies of SflSdd-CBE (nSaCas9) 2.0 at the Pcsk9 site in liver tissue post-injection of AAV8 at 5 × 10 11 total genome copies. (D-E) Four-week post-injection quantification of total serum cholesterol levels ( D ), serum ALB levels ( E ), serum ALT levels ( F ) and serum AST levels ( G ) (PBS, n = 5; AAV8- PCSK9 , n = 4). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Aav8 Vector, supplied by PackGene Biotech lnc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav8/pmc11472066-97-1-7?v=PackGene+Biotech+lnc
Average 95 stars, based on 1 article reviews
aav8 vector - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier
adeno associated virus serotype 8 aav8  (Vector Biolabs)
95
Vector Biolabs adeno associated virus serotype 8 aav8
In vivo mouse PCSK9 gene editing using single <t>AAV8</t> - packaged SflSdd-CBE (nSaCas9) 2.0. ( A ) Theoretical packaging of SflSdd-CBE (nSaCas9) 2.0 into a single AAV8. The top, shows the architectures of AncBE4max (nSaCas9), BE4-gam (nSaCas9), and Sdd-CBE (nSaCas9) 2.0, with AncBE4max (nSaCas9) and BE4-gam (nSaCas9) in gray, indicating their size exceeds the single AAV packaging limit. The bottom presents a schematic representation of AAV8-SflSdd-CBE (nSaCas9) 2.0. ( B ) Experimental timeline for tail-vein injections and subsequent analyses using AAV8-SflSdd-CBE (nSaCas9) 2.0. ( C ) Editing efficiencies of SflSdd-CBE (nSaCas9) 2.0 at the Pcsk9 site in liver tissue post-injection of AAV8 at 5 × 10 11 total genome copies. (D-E) Four-week post-injection quantification of total serum cholesterol levels ( D ), serum ALB levels ( E ), serum ALT levels ( F ) and serum AST levels ( G ) (PBS, n = 5; AAV8- PCSK9 , n = 4). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Adeno Associated Virus Serotype 8 Aav8, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav8/pm37942005-202-8-28?v=Vector+Biolabs
Average 95 stars, based on 1 article reviews
adeno associated virus serotype 8 aav8 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier
vigene n a aav5 u6  (Vigene Biosciences)
86
Vigene Biosciences vigene n a aav5 u6
In vivo mouse PCSK9 gene editing using single <t>AAV8</t> - packaged SflSdd-CBE (nSaCas9) 2.0. ( A ) Theoretical packaging of SflSdd-CBE (nSaCas9) 2.0 into a single AAV8. The top, shows the architectures of AncBE4max (nSaCas9), BE4-gam (nSaCas9), and Sdd-CBE (nSaCas9) 2.0, with AncBE4max (nSaCas9) and BE4-gam (nSaCas9) in gray, indicating their size exceeds the single AAV packaging limit. The bottom presents a schematic representation of AAV8-SflSdd-CBE (nSaCas9) 2.0. ( B ) Experimental timeline for tail-vein injections and subsequent analyses using AAV8-SflSdd-CBE (nSaCas9) 2.0. ( C ) Editing efficiencies of SflSdd-CBE (nSaCas9) 2.0 at the Pcsk9 site in liver tissue post-injection of AAV8 at 5 × 10 11 total genome copies. (D-E) Four-week post-injection quantification of total serum cholesterol levels ( D ), serum ALB levels ( E ), serum ALT levels ( F ) and serum AST levels ( G ) (PBS, n = 5; AAV8- PCSK9 , n = 4). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Vigene N A Aav5 U6, supplied by Vigene Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav8/pm38614102-207-193-193?v=Vigene+Biosciences
Average 86 stars, based on 1 article reviews
vigene n a aav5 u6 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
aav8 hsyn  (Addgene inc)
93
Addgene inc aav8 hsyn
In vivo mouse PCSK9 gene editing using single <t>AAV8</t> - packaged SflSdd-CBE (nSaCas9) 2.0. ( A ) Theoretical packaging of SflSdd-CBE (nSaCas9) 2.0 into a single AAV8. The top, shows the architectures of AncBE4max (nSaCas9), BE4-gam (nSaCas9), and Sdd-CBE (nSaCas9) 2.0, with AncBE4max (nSaCas9) and BE4-gam (nSaCas9) in gray, indicating their size exceeds the single AAV packaging limit. The bottom presents a schematic representation of AAV8-SflSdd-CBE (nSaCas9) 2.0. ( B ) Experimental timeline for tail-vein injections and subsequent analyses using AAV8-SflSdd-CBE (nSaCas9) 2.0. ( C ) Editing efficiencies of SflSdd-CBE (nSaCas9) 2.0 at the Pcsk9 site in liver tissue post-injection of AAV8 at 5 × 10 11 total genome copies. (D-E) Four-week post-injection quantification of total serum cholesterol levels ( D ), serum ALB levels ( E ), serum ALT levels ( F ) and serum AST levels ( G ) (PBS, n = 5; AAV8- PCSK9 , n = 4). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Aav8 Hsyn, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav8/pm41057656-54-9-10?v=Addgene+inc
Average 93 stars, based on 1 article reviews
aav8 hsyn - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
scaav8 cmv egfp  (PackGene Biotech lnc)
95
PackGene Biotech lnc scaav8 cmv egfp
In vivo mouse PCSK9 gene editing using single <t>AAV8</t> - packaged SflSdd-CBE (nSaCas9) 2.0. ( A ) Theoretical packaging of SflSdd-CBE (nSaCas9) 2.0 into a single AAV8. The top, shows the architectures of AncBE4max (nSaCas9), BE4-gam (nSaCas9), and Sdd-CBE (nSaCas9) 2.0, with AncBE4max (nSaCas9) and BE4-gam (nSaCas9) in gray, indicating their size exceeds the single AAV packaging limit. The bottom presents a schematic representation of AAV8-SflSdd-CBE (nSaCas9) 2.0. ( B ) Experimental timeline for tail-vein injections and subsequent analyses using AAV8-SflSdd-CBE (nSaCas9) 2.0. ( C ) Editing efficiencies of SflSdd-CBE (nSaCas9) 2.0 at the Pcsk9 site in liver tissue post-injection of AAV8 at 5 × 10 11 total genome copies. (D-E) Four-week post-injection quantification of total serum cholesterol levels ( D ), serum ALB levels ( E ), serum ALT levels ( F ) and serum AST levels ( G ) (PBS, n = 5; AAV8- PCSK9 , n = 4). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Scaav8 Cmv Egfp, supplied by PackGene Biotech lnc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav8/pmc10978582-45-16-19?v=PackGene+Biotech+lnc
Average 95 stars, based on 1 article reviews
scaav8 cmv egfp - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier
aav8  (Vector Biolabs)
95
Vector Biolabs aav8
In vivo mouse PCSK9 gene editing using single <t>AAV8</t> - packaged SflSdd-CBE (nSaCas9) 2.0. ( A ) Theoretical packaging of SflSdd-CBE (nSaCas9) 2.0 into a single AAV8. The top, shows the architectures of AncBE4max (nSaCas9), BE4-gam (nSaCas9), and Sdd-CBE (nSaCas9) 2.0, with AncBE4max (nSaCas9) and BE4-gam (nSaCas9) in gray, indicating their size exceeds the single AAV packaging limit. The bottom presents a schematic representation of AAV8-SflSdd-CBE (nSaCas9) 2.0. ( B ) Experimental timeline for tail-vein injections and subsequent analyses using AAV8-SflSdd-CBE (nSaCas9) 2.0. ( C ) Editing efficiencies of SflSdd-CBE (nSaCas9) 2.0 at the Pcsk9 site in liver tissue post-injection of AAV8 at 5 × 10 11 total genome copies. (D-E) Four-week post-injection quantification of total serum cholesterol levels ( D ), serum ALB levels ( E ), serum ALT levels ( F ) and serum AST levels ( G ) (PBS, n = 5; AAV8- PCSK9 , n = 4). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Aav8, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav8/pmc07470898-14-11-13?v=Vector+Biolabs
Average 95 stars, based on 1 article reviews
aav8 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier
aav8 hsyn hm4d gi mcherry  (Vector Biolabs)
95
Vector Biolabs aav8 hsyn hm4d gi mcherry
In vivo mouse PCSK9 gene editing using single <t>AAV8</t> - packaged SflSdd-CBE (nSaCas9) 2.0. ( A ) Theoretical packaging of SflSdd-CBE (nSaCas9) 2.0 into a single AAV8. The top, shows the architectures of AncBE4max (nSaCas9), BE4-gam (nSaCas9), and Sdd-CBE (nSaCas9) 2.0, with AncBE4max (nSaCas9) and BE4-gam (nSaCas9) in gray, indicating their size exceeds the single AAV packaging limit. The bottom presents a schematic representation of AAV8-SflSdd-CBE (nSaCas9) 2.0. ( B ) Experimental timeline for tail-vein injections and subsequent analyses using AAV8-SflSdd-CBE (nSaCas9) 2.0. ( C ) Editing efficiencies of SflSdd-CBE (nSaCas9) 2.0 at the Pcsk9 site in liver tissue post-injection of AAV8 at 5 × 10 11 total genome copies. (D-E) Four-week post-injection quantification of total serum cholesterol levels ( D ), serum ALB levels ( E ), serum ALT levels ( F ) and serum AST levels ( G ) (PBS, n = 5; AAV8- PCSK9 , n = 4). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Aav8 Hsyn Hm4d Gi Mcherry, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav8/pmc06898730-123-10-21?v=Vector+Biolabs
Average 95 stars, based on 1 article reviews
aav8 hsyn hm4d gi mcherry - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier
aav8 tbg null  (Vector Biolabs)
95
Vector Biolabs aav8 tbg null
In vivo mouse PCSK9 gene editing using single <t>AAV8</t> - packaged SflSdd-CBE (nSaCas9) 2.0. ( A ) Theoretical packaging of SflSdd-CBE (nSaCas9) 2.0 into a single AAV8. The top, shows the architectures of AncBE4max (nSaCas9), BE4-gam (nSaCas9), and Sdd-CBE (nSaCas9) 2.0, with AncBE4max (nSaCas9) and BE4-gam (nSaCas9) in gray, indicating their size exceeds the single AAV packaging limit. The bottom presents a schematic representation of AAV8-SflSdd-CBE (nSaCas9) 2.0. ( B ) Experimental timeline for tail-vein injections and subsequent analyses using AAV8-SflSdd-CBE (nSaCas9) 2.0. ( C ) Editing efficiencies of SflSdd-CBE (nSaCas9) 2.0 at the Pcsk9 site in liver tissue post-injection of AAV8 at 5 × 10 11 total genome copies. (D-E) Four-week post-injection quantification of total serum cholesterol levels ( D ), serum ALB levels ( E ), serum ALT levels ( F ) and serum AST levels ( G ) (PBS, n = 5; AAV8- PCSK9 , n = 4). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Aav8 Tbg Null, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav8/bio_rxiv__2025__11__26__690789-38-23-24?v=Vector+Biolabs
Average 95 stars, based on 1 article reviews
aav8 tbg null - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier
aav8 adeno associated virus serotype 8 expressing mouse ism1  (Vector Biolabs)
95
Vector Biolabs aav8 adeno associated virus serotype 8 expressing mouse ism1
In vivo mouse PCSK9 gene editing using single <t>AAV8</t> - packaged SflSdd-CBE (nSaCas9) 2.0. ( A ) Theoretical packaging of SflSdd-CBE (nSaCas9) 2.0 into a single AAV8. The top, shows the architectures of AncBE4max (nSaCas9), BE4-gam (nSaCas9), and Sdd-CBE (nSaCas9) 2.0, with AncBE4max (nSaCas9) and BE4-gam (nSaCas9) in gray, indicating their size exceeds the single AAV packaging limit. The bottom presents a schematic representation of AAV8-SflSdd-CBE (nSaCas9) 2.0. ( B ) Experimental timeline for tail-vein injections and subsequent analyses using AAV8-SflSdd-CBE (nSaCas9) 2.0. ( C ) Editing efficiencies of SflSdd-CBE (nSaCas9) 2.0 at the Pcsk9 site in liver tissue post-injection of AAV8 at 5 × 10 11 total genome copies. (D-E) Four-week post-injection quantification of total serum cholesterol levels ( D ), serum ALB levels ( E ), serum ALT levels ( F ) and serum AST levels ( G ) (PBS, n = 5; AAV8- PCSK9 , n = 4). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Aav8 Adeno Associated Virus Serotype 8 Expressing Mouse Ism1, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav8/pm34348115-381-5-22?v=Vector+Biolabs
Average 95 stars, based on 1 article reviews
aav8 adeno associated virus serotype 8 expressing mouse ism1 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier
aav8 tbg icre  (Vector Biolabs)
93
Vector Biolabs aav8 tbg icre
In vivo mouse PCSK9 gene editing using single <t>AAV8</t> - packaged SflSdd-CBE (nSaCas9) 2.0. ( A ) Theoretical packaging of SflSdd-CBE (nSaCas9) 2.0 into a single AAV8. The top, shows the architectures of AncBE4max (nSaCas9), BE4-gam (nSaCas9), and Sdd-CBE (nSaCas9) 2.0, with AncBE4max (nSaCas9) and BE4-gam (nSaCas9) in gray, indicating their size exceeds the single AAV packaging limit. The bottom presents a schematic representation of AAV8-SflSdd-CBE (nSaCas9) 2.0. ( B ) Experimental timeline for tail-vein injections and subsequent analyses using AAV8-SflSdd-CBE (nSaCas9) 2.0. ( C ) Editing efficiencies of SflSdd-CBE (nSaCas9) 2.0 at the Pcsk9 site in liver tissue post-injection of AAV8 at 5 × 10 11 total genome copies. (D-E) Four-week post-injection quantification of total serum cholesterol levels ( D ), serum ALB levels ( E ), serum ALT levels ( F ) and serum AST levels ( G ) (PBS, n = 5; AAV8- PCSK9 , n = 4). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Aav8 Tbg Icre, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav8/pm34903884-250-0-10?v=Vector+Biolabs
Average 93 stars, based on 1 article reviews
aav8 tbg icre - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
virus strains aav8 gfp shanghai genechem co  (Shanghai Genechem Ltd)
86
Shanghai Genechem Ltd virus strains aav8 gfp shanghai genechem co
In vivo mouse PCSK9 gene editing using single <t>AAV8</t> - packaged SflSdd-CBE (nSaCas9) 2.0. ( A ) Theoretical packaging of SflSdd-CBE (nSaCas9) 2.0 into a single AAV8. The top, shows the architectures of AncBE4max (nSaCas9), BE4-gam (nSaCas9), and Sdd-CBE (nSaCas9) 2.0, with AncBE4max (nSaCas9) and BE4-gam (nSaCas9) in gray, indicating their size exceeds the single AAV packaging limit. The bottom presents a schematic representation of AAV8-SflSdd-CBE (nSaCas9) 2.0. ( B ) Experimental timeline for tail-vein injections and subsequent analyses using AAV8-SflSdd-CBE (nSaCas9) 2.0. ( C ) Editing efficiencies of SflSdd-CBE (nSaCas9) 2.0 at the Pcsk9 site in liver tissue post-injection of AAV8 at 5 × 10 11 total genome copies. (D-E) Four-week post-injection quantification of total serum cholesterol levels ( D ), serum ALB levels ( E ), serum ALT levels ( F ) and serum AST levels ( G ) (PBS, n = 5; AAV8- PCSK9 , n = 4). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Virus Strains Aav8 Gfp Shanghai Genechem Co, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav8/pm42097136-350-46-49?v=Shanghai+Genechem+Ltd
Average 86 stars, based on 1 article reviews
virus strains aav8 gfp shanghai genechem co - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
aav8 cag egfp  (Vector Biolabs)
95
Vector Biolabs aav8 cag egfp
In vivo mouse PCSK9 gene editing using single <t>AAV8</t> - packaged SflSdd-CBE (nSaCas9) 2.0. ( A ) Theoretical packaging of SflSdd-CBE (nSaCas9) 2.0 into a single AAV8. The top, shows the architectures of AncBE4max (nSaCas9), BE4-gam (nSaCas9), and Sdd-CBE (nSaCas9) 2.0, with AncBE4max (nSaCas9) and BE4-gam (nSaCas9) in gray, indicating their size exceeds the single AAV packaging limit. The bottom presents a schematic representation of AAV8-SflSdd-CBE (nSaCas9) 2.0. ( B ) Experimental timeline for tail-vein injections and subsequent analyses using AAV8-SflSdd-CBE (nSaCas9) 2.0. ( C ) Editing efficiencies of SflSdd-CBE (nSaCas9) 2.0 at the Pcsk9 site in liver tissue post-injection of AAV8 at 5 × 10 11 total genome copies. (D-E) Four-week post-injection quantification of total serum cholesterol levels ( D ), serum ALB levels ( E ), serum ALT levels ( F ) and serum AST levels ( G ) (PBS, n = 5; AAV8- PCSK9 , n = 4). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
Aav8 Cag Egfp, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav8/pmc09464962-255-20-29?v=Vector+Biolabs
Average 95 stars, based on 1 article reviews
aav8 cag egfp - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

Image Search Results


In vivo mouse PCSK9 gene editing using single AAV8 - packaged SflSdd-CBE (nSaCas9) 2.0. ( A ) Theoretical packaging of SflSdd-CBE (nSaCas9) 2.0 into a single AAV8. The top, shows the architectures of AncBE4max (nSaCas9), BE4-gam (nSaCas9), and Sdd-CBE (nSaCas9) 2.0, with AncBE4max (nSaCas9) and BE4-gam (nSaCas9) in gray, indicating their size exceeds the single AAV packaging limit. The bottom presents a schematic representation of AAV8-SflSdd-CBE (nSaCas9) 2.0. ( B ) Experimental timeline for tail-vein injections and subsequent analyses using AAV8-SflSdd-CBE (nSaCas9) 2.0. ( C ) Editing efficiencies of SflSdd-CBE (nSaCas9) 2.0 at the Pcsk9 site in liver tissue post-injection of AAV8 at 5 × 10 11 total genome copies. (D-E) Four-week post-injection quantification of total serum cholesterol levels ( D ), serum ALB levels ( E ), serum ALT levels ( F ) and serum AST levels ( G ) (PBS, n = 5; AAV8- PCSK9 , n = 4). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Journal: Nucleic Acids Research

Article Title: Accelerated discovery and miniaturization of novel single-stranded cytidine deaminases

doi: 10.1093/nar/gkae800

Figure Lengend Snippet: In vivo mouse PCSK9 gene editing using single AAV8 - packaged SflSdd-CBE (nSaCas9) 2.0. ( A ) Theoretical packaging of SflSdd-CBE (nSaCas9) 2.0 into a single AAV8. The top, shows the architectures of AncBE4max (nSaCas9), BE4-gam (nSaCas9), and Sdd-CBE (nSaCas9) 2.0, with AncBE4max (nSaCas9) and BE4-gam (nSaCas9) in gray, indicating their size exceeds the single AAV packaging limit. The bottom presents a schematic representation of AAV8-SflSdd-CBE (nSaCas9) 2.0. ( B ) Experimental timeline for tail-vein injections and subsequent analyses using AAV8-SflSdd-CBE (nSaCas9) 2.0. ( C ) Editing efficiencies of SflSdd-CBE (nSaCas9) 2.0 at the Pcsk9 site in liver tissue post-injection of AAV8 at 5 × 10 11 total genome copies. (D-E) Four-week post-injection quantification of total serum cholesterol levels ( D ), serum ALB levels ( E ), serum ALT levels ( F ) and serum AST levels ( G ) (PBS, n = 5; AAV8- PCSK9 , n = 4). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Article Snippet: The AAV8 vector was also made by Packgene Biotech Company.

Techniques: In Vivo, Injection